Hangad, NiƱo Jan Andrey C.

HRN: 24-08-71  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/16/2023
11/26/2023
IV
300 Mg
Q8 Hrs
Bleeding Abdominal Mass
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: